PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 6 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Cistifolin from the rhizome inhibited oedema formation in rat paw models of carrageenan-induced inflammation in a dose-dependent manner (10 and 50 mg/kg) [PMID:10075543].
Evidence summary
PubMed sources
- 1.PMID: 11746861 (2001) — Antiinflammatory activity of the antirheumatic herbal drug, gravel root (Eupatorium purpureum): further biological activities and constituents. · Phytotherapy research : PTR
- 2.PMID: 31963839 (2020) — Volatile Compositions and Antifungal Activities of Native American Medicinal Plants: Focus on the Asteraceae. · Plants (Basel, Switzerland)
- 3.PMID: 10075543 (1998) — Cistifolin, an integrin-dependent cell adhesion blocker from the anti-rheumatic herbal drug, gravel root (rhizome of Eupatorium purpureum). · Planta medica